Literature DB >> 7916071

Evidence from family studies for autoimmunity in dilated cardiomyopathy.

A L Caforio1, P J Keeling, E Zachara, L Mestroni, F Camerini, J M Mann, G F Bottazzo, W J McKenna.   

Abstract

Organ-specific antibodies are found in patients with autoimmune disease and their symptom-free relatives many years before clinical onset. Organ-specific cardiac antibodies can be found in patients with dilated cardiomyopathy (DCM) and their relatives, which supports the idea that DCM is an autoimmune disease. We did non-invasive cardiological assessment and antibody screening in 342 symptom-free relatives (170 male, 172 female, mean [SD] age 31 [16] years). 177 relatives were from 33 families with more than 1 affected individual (familial DCM) and 165 relatives from 31 families with only 1 affected member (non-familial DCM). The frequency of cardiac antibodies was higher among relatives of DCM patients than in controls (20% vs 3.5%, p = 0.0001). In 37 (58%) of the families studied, cardiac antibodies were found in the proband and/or in at least 1 family member and were more common in familial than in non-familial DCM (24% vs 15%, p = 0.036). Antibody-positive relatives were younger (26 [15] vs 33 [17] years, p = 0.01) and had a larger mean echocardiographic left ventricular end-systolic dimension (35 [6] vs 32 [6], p = 0.01 mm) and reduced percentage fractional shortening compared with antibody-negative relatives (31 [6] vs 34 [6], p = 0.008). Presence of cardiac-specific autoantibodies in symptom-free DCM relatives provides evidence of autoimmunity in a subset of our patients (58%), including familial and non-familial forms of DCM. These antibodies are associated with mild left ventricular systolic dysfunction on echocardiography and may be early markers for relatives at risk of DCM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916071     DOI: 10.1016/s0140-6736(94)92339-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution.

Authors:  C J McKenna; M B Codd; H A McCann; D D Sugrue
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression.

Authors:  A L Caforio; J H Goldman; M K Baig; A J Haven; L Dalla Libera; P J Keeling; W J McKenna
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

3.  Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives.

Authors:  J B Marriott; J H Goldman; P J Keeling; M K Baig; A G Dalgleish; W J McKenna
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

4.  IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease.

Authors:  P Skyllouriotis; M Skyllouriotis-Lazarou; S Natter; R Steiner; S Spitzauer; S Kapiotis; P Valent; A M Hirschl; S E Guber; G Laufer; G Wollenek; E Wolner; M Wimmer; R Valenta
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 5.  Role of impaired central tolerance to α-myosin in inflammatory heart disease.

Authors:  HuiJuan Lv; Myra A Lipes
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

6.  Absence of viral nucleic acids in early and late dilated cardiomyopathy.

Authors:  N G Mahon; B Zal; G Arno; P Risley; J Pinto-Basto; W J McKenna; M J Davies; C Baboonian
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 7.  Recognition and optimum management of myocarditis.

Authors:  A L Caforio; W J McKenna
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 8.  Role of autoimmunity in dilated cardiomyopathy.

Authors:  A L Caforio
Journal:  Br Heart J       Date:  1994-12

Review 9.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy.

Authors:  J H Goldman; P J Keeling; R S Warraich; M K Baig; S R Redwood; L Dalla Libera; J E Sanderson; A L Caforio; W J McKenna
Journal:  Br Heart J       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.